[1] 国家统计局, 国务院第七次全国人口普查领导小组办公室. 第七次全国人口普查公报(第一号):第七次全国人口普查工作基本情况[J]. 中国统计, 2021(5):6-7. [2] 徐兰, 赵雪兰, 赵霞娟, 等. 健康老年人肾功能增龄性下降与早期动脉硬化的相关性研究[J]. 中国老年保健医学, 2023, 21(2):29-33. [3] 王善志, 朱永俊, 唐文庄, 等. 中国成人及老年人群慢性肾脏病患病率Meta分析[J]. 中国老年学杂志, 2017, 37(21):5384-5388. [4] JIAN Y, ZHU D, ZHOU D, et al. ARIMA model for predicting chronic kidney disease and estimating its economic burden in China[J]. BMC Public Health, 2022, 22(1):2456. [5] LI L, YANG C, ZHAO Y, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?:a systematic review and meta-analysis based on observational cohort studies[J]. BMC Nephrol, 2014, 15:122. [6] BARATA R, CARDOSO F, PEREIRA T A. Hyperuricemia in chronic kidney disease: a role yet to be explained[J]. Port J Nephrol Hypert, 2020, 34(1):30-35. [7] ZHU P, LIU Y, HAN L, et al. Serum uric acid is associated with incident chronic kidney disease in middle-aged populations:a meta-analysis of 15 cohort studies[J]. PLoS One, 2014, 9(6):e100801. [8] BEN-DOV I Z, KARK J D. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study[J]. Nephrol Dial Transplant, 2011, 26(8):2558-2566. [9] GU L, HUANG L, WU H, et al. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function [J]. Diab Vasc Dis Res, 2017, 14(3):221-225. [10] KURIYAMA S, MARUYAMA Y, NISHIO S, et al. Serum uric acid and the incidence of CKD and hypertension [J]. Clin Exp Nephrol, 2015, 19(6):1127-1134. [11] STEVENS P E, LEVIN A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med, 2013, 158(11):825-830. [12] GRAMS M E, SANG Y, BALLEW S H, et al. Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data[J]. J Am Soc Nephrol, 2019, 30(9):1746-1755. [13] HSIEH Y P, CHANG C C, YANG Y, et al. The role of uric acid in chronic kidney disease patients[J]. Nephrology: Carlton, 2017, 22(6):441-448. [14] SON Y B, YANG J H, KIM M G, et al. The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: a health checkup cohort study[J]. PLoS One, 2021, 16(1):e0244106. [15] NAKAYAMA S, SATOH M, TATSUMI Y, et al. Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults[J]. Atherosclerosis, 2021, 330:107-113. [16] 黄迁, 徐健, 袁雪丽, 等. 深圳市社区65岁及以上老年人高尿酸血症与慢性肾病的相关性研究[J]. 中国慢性病预防与控制, 2023, 31(8):606-610. [17] SILVA N R, GONÇALVES C E T, GONÇALVES D L N, et al. Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients[J]. BMC Nephrol, 2021, 22(1):311. [18] CHANG W X, XU N, KUMAGAI T, et al. Uric acid in the follow-up determines 30% decline in estimated GFR over 2 years: a propensity score analysis[J]. Kidney Blood Press Res, 2017, 42(6):1053-1067. [19] MULAY S R. Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases[J]. Kidney Int, 2019, 96(1):58-66. [20] RUSSO E, VERZOLA D, CAPPADONA F, et al. The role of uric acid in renal damage-a history of inflammatory pathways and vascular remodeling[J]. Vessel Plus, 2021, 5:15. [21] KIELSTEIN J T, PONTREMOLI R, BURNIER M. Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection[J]. Curr Hypertens Rep, 2020, 22(12):1-11. |